Moreover, ST2 expression was upregulated in 87% of metastatic OvC and 66% of primary sites when compared to normal human ovarian tissue samples, which was more pronounced than the increase of the IL-33 level in 77% of metastatic ovarian tumors and 60% of primary sites (Tong et al., 2016). The gene discussed is IL33; the disease is ovarian neoplasm.